iCo Therapeutics
- ICO
- TSX Venture
- Consumer Products
- Latest 0.325
- Currency C$
- Change
- Percent Change
- Volume 375,978
- Wed May 22, 2013 2:45 PM EDT TSX Venture data delayed 15 minutes.
The Globe and Mail
- Open 0.34
- Previous Close 0.325
- High 0.34
- Low 0.315
- Bidx39 0.315
- Askx16 0.325
- 52-week High 01/03 0.89
- 52-week Low 05/24 0.245
- Beta 0.441
- Market Cap 15.16M
- EPS -0.02
- P/E --
- Forward P/E 4.643
- PEG --
- Annual Dividend --
- Yield --
News
Financials & Calendars
- Sales $1,441,117
- Earnings $-1,032,011
- Return on Equity n/a
- Cash Flow $-1,893,658
- Cash $255,548
- Current Ratio 5.48
12 months ended Dec 31, 2011.
Trailing 12 month results shown above.
All data is in Canadian dollars.
- Assets $2,945,929
- Liabilities $255,139
- Liabilities-to-Equity Ratio 0.09
Price Ratios
- Price to Sales n/a
- Price to Book 5.60
- Price to Cash Flow -7.22
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | May 1 | n/a | May 30 | n/a |
| Surprises | n/a | n/a | n/a | n/a |
| Dividends | n/a | n/a | n/a | n/a |
| Splits | n/a | -- | n/a | n/a |
12 months ended May 22, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
ICO THERAPEUTICS INC. is a Vancouver-based reprofiling company focused on redosing or reformulating drugs with clinical history for new or expanded indications.
Officers
- Andrew Rae President & C.EO. & Director
- John Meekison C.F.O.
- Company Type: PUBLIC
- Company Status: Active
- Full-time Employees: n/a
-
Incorporation:
Canada,
Apr 2, 2006 -
Top 1000 Ranking:
Profit: 0
Revenue: 0
Assets: 0
Head Office
760 - 777 Hornby StreetVancouver, BC
V6Z 1S4
Phone: (604)-602-9414
Fax: (604)-6029699
Ideas & Discussion
Live Discussion of ICO on StockTwits